Illumina Revenues Up
Illumina reported increased revenues for the first quarter last week, amid nearly flat net losses.
The San Diego genotyping and oligonucleotide company’s revenues for the quarter totaled $4.3 million, up from $1.3 million for the year-ago quarter. Net losses totaled $9.0 million, up from $8.7 million for the first quarter of 2002. Research and development expenses were $5.7 million, from $7.1 million in Q1 2002.
Nanosys GET New Funders in $30M Series B